MEXICO CITY, April 7 (Reuters) - Mexico's drug regulator
Cofepris said on Wednesday it has no current plans to limit the
use of the Oxford/AstraZeneca COVID-19 vaccine to any
age or group, after Britain's vaccine advisory committee cited
safety concerns over its use on people under the age of 30.
Cofepris is investigating the issue and awaiting further
information, it said in a statement to Reuters.
(Reporting by Cassandra Garrison; Editing by Anthony Esposito)